Editorial: Another brick in the CDST wall: Authors' reply-Reference-Cited by-同舟云学术

Editorial: Another brick in the CDST wall: Authors' reply

Published:2024-05-17 Issue:1 Volume:60 Page:87-88
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kim Kyuwon¹^ORCID,Ye Byong Duk²³^ORCID

Affiliation:

1. Department of Internal Medicine Chung‐Ang University Hospital, Chung‐Ang University College of Medicine Seoul Republic of Korea

2. Department of Gastroenterology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

3. Inflammatory Bowel Disease Center Asan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea

Abstract

LINKED CONTENTThis article is linked to Kim et al papers. To view these articles, visit https://doi.org/10.1111/apt.17989 and https://doi.org/10.1111/apt.18023.

Funder

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18045

Reference10 articles.

1. Editorial: another brick in the CDST wall;Amiot A;Aliment Pharmacol Ther,2024

2. Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: a KASID multicentre study;Kim K;Aliment Pharmacol Ther,2024

3. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

4. Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

5. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis